HEADER TRANSFERASE 03-SEP-12 4B99 TITLE CRYSTAL STRUCTURE OF MAPK7 (ERK5) WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 7; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: MAP KINASE 7, MAPK 7, BIG MAP KINASE 1, BMK-1, EXTRACELLULAR COMPND 6 SIGNAL-REGULATED KINASE 5, ERK-5; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFB-LIC-BSE KEYWDS TRANSFERASE, INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR J.M.ELKINS,J.WANG,M.VOLLMAR,P.MAHAJAN,P.SAVITSKY,X.DENG,N.S.GRAY, AUTHOR 2 A.C.W.PIKE,F.VON DELFT,C.BOUNTRA,C.ARROWSMITH,A.EDWARDS,S.KNAPP REVDAT 5 20-DEC-23 4B99 1 REMARK REVDAT 4 24-JAN-18 4B99 1 AUTHOR REVDAT 3 26-JUN-13 4B99 1 JRNL REVDAT 2 22-MAY-13 4B99 1 JRNL REVDAT 1 19-SEP-12 4B99 0 JRNL AUTH J.M.ELKINS,J.WANG,X.DENG,M.J.PATTISON,S.ARTHUR,T.ERAZO, JRNL AUTH 2 N.GOMEZ,J.M.LIZCANO,N.S.GRAY,S.KNAPP JRNL TITL X-RAY CRYSTAL STRUCTURE OF ERK5 (MAPK7) IN COMPLEX WITH A JRNL TITL 2 SPECIFIC INHIBITOR. JRNL REF J.MED.CHEM. V. 56 4413 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23656407 JRNL DOI 10.1021/JM4000837 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0029 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 74.42 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 13129 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.225 REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.287 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 688 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 REFLECTION IN BIN (WORKING SET) : 924 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.82 REMARK 3 BIN R VALUE (WORKING SET) : 0.2680 REMARK 3 BIN FREE R VALUE SET COUNT : 51 REMARK 3 BIN FREE R VALUE : 0.3270 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2604 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 9 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 72.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.21000 REMARK 3 B22 (A**2) : -0.21000 REMARK 3 B33 (A**2) : 0.42000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.657 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.370 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.280 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 28.977 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.907 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.846 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2718 ; 0.006 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2586 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3697 ; 1.185 ; 1.982 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5914 ; 0.899 ; 3.008 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 332 ; 5.668 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 114 ;34.843 ;22.982 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 431 ;16.318 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;16.902 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 411 ; 0.060 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3043 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 628 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 0 A 139 REMARK 3 ORIGIN FOR THE GROUP (A): -54.5640 8.8530 -15.9760 REMARK 3 T TENSOR REMARK 3 T11: 0.2929 T22: 0.2474 REMARK 3 T33: 0.0692 T12: -0.0269 REMARK 3 T13: 0.0606 T23: 0.0060 REMARK 3 L TENSOR REMARK 3 L11: 5.5193 L22: 2.2757 REMARK 3 L33: 3.7309 L12: -0.3254 REMARK 3 L13: -0.3666 L23: 1.4859 REMARK 3 S TENSOR REMARK 3 S11: -0.3470 S12: 0.2245 S13: -0.4269 REMARK 3 S21: -0.1203 S22: 0.0973 S23: 0.2575 REMARK 3 S31: 0.0441 S32: -0.3512 S33: 0.2497 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 140 A 397 REMARK 3 ORIGIN FOR THE GROUP (A): -32.9370 14.4400 -6.0740 REMARK 3 T TENSOR REMARK 3 T11: 0.2976 T22: 0.4032 REMARK 3 T33: 0.0342 T12: -0.1157 REMARK 3 T13: 0.0164 T23: -0.0047 REMARK 3 L TENSOR REMARK 3 L11: 3.4741 L22: 1.1455 REMARK 3 L33: 3.5176 L12: 0.4919 REMARK 3 L13: -0.5352 L23: 0.0805 REMARK 3 S TENSOR REMARK 3 S11: -0.0809 S12: -0.5132 S13: -0.0223 REMARK 3 S21: 0.1167 S22: 0.0320 S23: -0.1636 REMARK 3 S31: -0.3745 S32: 0.6058 S33: 0.0489 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4B99 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-SEP-12. REMARK 100 THE DEPOSITION ID IS D_1290053878. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JUL-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9686 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13868 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 74.420 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.99 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.10 REMARK 200 R MERGE FOR SHELL (I) : 0.71000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3GC9 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05M CACL2, 0.1M MES PH 6.0, 20% PEG REMARK 280 6000, 10% ETHYLENE GLYCOL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 59.72500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 47.57500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 47.57500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 29.86250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 47.57500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 47.57500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 89.58750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 47.57500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.57500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 29.86250 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 47.57500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.57500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 89.58750 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 59.72500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 GLU A 3 REMARK 465 PRO A 4 REMARK 465 LEU A 5 REMARK 465 LYS A 6 REMARK 465 GLU A 7 REMARK 465 GLU A 8 REMARK 465 ASP A 9 REMARK 465 GLY A 10 REMARK 465 GLU A 11 REMARK 465 ASP A 12 REMARK 465 GLY A 13 REMARK 465 SER A 14 REMARK 465 ALA A 15 REMARK 465 GLU A 16 REMARK 465 PRO A 17 REMARK 465 PRO A 18 REMARK 465 GLY A 19 REMARK 465 PRO A 20 REMARK 465 VAL A 21 REMARK 465 LYS A 22 REMARK 465 ALA A 23 REMARK 465 GLU A 24 REMARK 465 PRO A 25 REMARK 465 ALA A 26 REMARK 465 HIS A 27 REMARK 465 THR A 28 REMARK 465 ALA A 29 REMARK 465 ALA A 30 REMARK 465 SER A 31 REMARK 465 VAL A 32 REMARK 465 ALA A 33 REMARK 465 ALA A 34 REMARK 465 LYS A 35 REMARK 465 ASN A 36 REMARK 465 LEU A 37 REMARK 465 ALA A 38 REMARK 465 LEU A 39 REMARK 465 LEU A 40 REMARK 465 LYS A 41 REMARK 465 ALA A 42 REMARK 465 ARG A 43 REMARK 465 SER A 44 REMARK 465 PHE A 45 REMARK 465 ASP A 46 REMARK 465 CYS A 208 REMARK 465 THR A 209 REMARK 465 SER A 210 REMARK 465 PRO A 211 REMARK 465 ALA A 212 REMARK 465 GLU A 213 REMARK 465 HIS A 214 REMARK 465 ALA A 288 REMARK 465 VAL A 289 REMARK 465 GLY A 290 REMARK 465 ALA A 291 REMARK 465 GLU A 292 REMARK 465 GLY A 394 REMARK 465 ILE A 395 REMARK 465 ARG A 396 REMARK 465 GLN A 397 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 47 CG1 CG2 REMARK 470 ASP A 50 CG OD1 OD2 REMARK 470 GLU A 54 CD OE1 OE2 REMARK 470 GLU A 59 CG CD OE1 OE2 REMARK 470 TYR A 66 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG A 73 CZ NH1 NH2 REMARK 470 LYS A 97 CE NZ REMARK 470 LYS A 110 CE NZ REMARK 470 GLU A 129 CD OE1 OE2 REMARK 470 LYS A 131 CE NZ REMARK 470 ARG A 181 CZ NH1 NH2 REMARK 470 ARG A 205 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 228 NE CZ NH1 NH2 REMARK 470 LEU A 234 CG CD1 CD2 REMARK 470 SER A 235 OG REMARK 470 LEU A 236 CG CD1 CD2 REMARK 470 HIS A 237 CG ND1 CD2 CE1 NE2 REMARK 470 GLU A 238 CG CD OE1 OE2 REMARK 470 LYS A 265 NZ REMARK 470 GLN A 287 CG CD OE1 NE2 REMARK 470 ARG A 293 CG CD NE CZ NH1 NH2 REMARK 470 TYR A 297 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ILE A 298 CG1 CG2 CD1 REMARK 470 GLN A 299 CG CD OE1 NE2 REMARK 470 SER A 300 OG REMARK 470 LEU A 301 CG CD1 CD2 REMARK 470 GLU A 310 CD OE1 OE2 REMARK 470 ARG A 318 CZ NH1 NH2 REMARK 470 LYS A 349 CD CE NZ REMARK 470 ARG A 369 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 370 CG CD OE1 OE2 REMARK 470 ARG A 376 CZ NH1 NH2 REMARK 470 GLU A 386 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 49 54.72 -157.91 REMARK 500 ILE A 58 -91.11 -104.28 REMARK 500 HIS A 149 62.26 -101.62 REMARK 500 ARG A 181 -22.01 75.02 REMARK 500 CYS A 194 14.29 57.93 REMARK 500 ASP A 200 87.29 69.90 REMARK 500 GLU A 220 -76.40 -78.73 REMARK 500 MET A 233 -72.74 -88.80 REMARK 500 SER A 235 91.85 -42.31 REMARK 500 HIS A 237 34.24 -98.42 REMARK 500 VAL A 285 49.59 -84.76 REMARK 500 ILE A 286 -84.90 -137.73 REMARK 500 PRO A 303 100.84 -55.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE R4L A 1394 DBREF 4B99 A 1 397 UNP Q13164 MK07_HUMAN 1 397 SEQADV 4B99 SER A 0 UNP Q13164 EXPRESSION TAG SEQRES 1 A 398 SER MET ALA GLU PRO LEU LYS GLU GLU ASP GLY GLU ASP SEQRES 2 A 398 GLY SER ALA GLU PRO PRO GLY PRO VAL LYS ALA GLU PRO SEQRES 3 A 398 ALA HIS THR ALA ALA SER VAL ALA ALA LYS ASN LEU ALA SEQRES 4 A 398 LEU LEU LYS ALA ARG SER PHE ASP VAL THR PHE ASP VAL SEQRES 5 A 398 GLY ASP GLU TYR GLU ILE ILE GLU THR ILE GLY ASN GLY SEQRES 6 A 398 ALA TYR GLY VAL VAL SER SER ALA ARG ARG ARG LEU THR SEQRES 7 A 398 GLY GLN GLN VAL ALA ILE LYS LYS ILE PRO ASN ALA PHE SEQRES 8 A 398 ASP VAL VAL THR ASN ALA LYS ARG THR LEU ARG GLU LEU SEQRES 9 A 398 LYS ILE LEU LYS HIS PHE LYS HIS ASP ASN ILE ILE ALA SEQRES 10 A 398 ILE LYS ASP ILE LEU ARG PRO THR VAL PRO TYR GLY GLU SEQRES 11 A 398 PHE LYS SER VAL TYR VAL VAL LEU ASP LEU MET GLU SER SEQRES 12 A 398 ASP LEU HIS GLN ILE ILE HIS SER SER GLN PRO LEU THR SEQRES 13 A 398 LEU GLU HIS VAL ARG TYR PHE LEU TYR GLN LEU LEU ARG SEQRES 14 A 398 GLY LEU LYS TYR MET HIS SER ALA GLN VAL ILE HIS ARG SEQRES 15 A 398 ASP LEU LYS PRO SER ASN LEU LEU VAL ASN GLU ASN CYS SEQRES 16 A 398 GLU LEU LYS ILE GLY ASP PHE GLY MET ALA ARG GLY LEU SEQRES 17 A 398 CYS THR SER PRO ALA GLU HIS GLN TYR PHE MET THR GLU SEQRES 18 A 398 TYR VAL ALA THR ARG TRP TYR ARG ALA PRO GLU LEU MET SEQRES 19 A 398 LEU SER LEU HIS GLU TYR THR GLN ALA ILE ASP LEU TRP SEQRES 20 A 398 SER VAL GLY CYS ILE PHE GLY GLU MET LEU ALA ARG ARG SEQRES 21 A 398 GLN LEU PHE PRO GLY LYS ASN TYR VAL HIS GLN LEU GLN SEQRES 22 A 398 LEU ILE MET MET VAL LEU GLY THR PRO SER PRO ALA VAL SEQRES 23 A 398 ILE GLN ALA VAL GLY ALA GLU ARG VAL ARG ALA TYR ILE SEQRES 24 A 398 GLN SER LEU PRO PRO ARG GLN PRO VAL PRO TRP GLU THR SEQRES 25 A 398 VAL TYR PRO GLY ALA ASP ARG GLN ALA LEU SER LEU LEU SEQRES 26 A 398 GLY ARG MET LEU ARG PHE GLU PRO SER ALA ARG ILE SER SEQRES 27 A 398 ALA ALA ALA ALA LEU ARG HIS PRO PHE LEU ALA LYS TYR SEQRES 28 A 398 HIS ASP PRO ASP ASP GLU PRO ASP CYS ALA PRO PRO PHE SEQRES 29 A 398 ASP PHE ALA PHE ASP ARG GLU ALA LEU THR ARG GLU ARG SEQRES 30 A 398 ILE LYS GLU ALA ILE VAL ALA GLU ILE GLU ASP PHE HIS SEQRES 31 A 398 ALA ARG ARG GLU GLY ILE ARG GLN HET R4L A1394 46 HETNAM R4L 11-CYCLOPENTYL-2-[[2-METHOXY-4-[4-(4-METHYLPIPERAZIN-1- HETNAM 2 R4L YL)PIPERIDIN-1-YL]CARBONYL-PHENYL]AMINO]-5-METHYL- HETNAM 3 R4L PYRIMIDO[4,5-B][1,4]BENZODIAZEPIN-6-ONE FORMUL 2 R4L C35 H44 N8 O3 FORMUL 3 HOH *9(H2 O) HELIX 1 1 VAL A 92 PHE A 109 1 18 HELIX 2 2 LEU A 144 HIS A 149 1 6 HELIX 3 3 THR A 155 ALA A 176 1 22 HELIX 4 4 LYS A 184 SER A 186 5 3 HELIX 5 5 ALA A 229 LEU A 234 1 6 HELIX 6 6 GLN A 241 ARG A 258 1 18 HELIX 7 7 ASN A 266 GLY A 279 1 14 HELIX 8 8 SER A 282 ILE A 286 5 5 HELIX 9 9 ARG A 293 SER A 300 1 8 HELIX 10 10 PRO A 308 TYR A 313 1 6 HELIX 11 11 ASP A 317 LEU A 328 1 12 HELIX 12 12 SER A 337 LEU A 342 1 6 HELIX 13 13 ARG A 343 ALA A 348 5 6 HELIX 14 14 ASP A 352 GLU A 356 5 5 HELIX 15 15 PHE A 365 GLU A 370 1 6 HELIX 16 16 THR A 373 GLU A 393 1 21 SHEET 1 AA 5 TYR A 55 ASN A 63 0 SHEET 2 AA 5 VAL A 68 ARG A 74 -1 O VAL A 69 N ILE A 61 SHEET 3 AA 5 GLN A 80 ILE A 86 -1 O VAL A 81 N ALA A 72 SHEET 4 AA 5 VAL A 133 ASP A 138 -1 O VAL A 133 N ILE A 86 SHEET 5 AA 5 ILE A 117 ILE A 120 -1 N LYS A 118 O VAL A 136 SHEET 1 AB 3 SER A 142 ASP A 143 0 SHEET 2 AB 3 LEU A 188 VAL A 190 -1 O VAL A 190 N SER A 142 SHEET 3 AB 3 LEU A 196 ILE A 198 -1 O LYS A 197 N LEU A 189 CISPEP 1 TYR A 66 GLY A 67 0 -2.71 CISPEP 2 ALA A 360 PRO A 361 0 9.51 SITE 1 AC1 15 ILE A 61 GLY A 62 ASN A 63 VAL A 69 SITE 2 AC1 15 LEU A 76 ILE A 115 LEU A 137 ASP A 138 SITE 3 AC1 15 MET A 140 GLU A 141 SER A 142 GLN A 146 SITE 4 AC1 15 SER A 186 LEU A 189 TYR A 221 CRYST1 95.150 95.150 119.450 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010510 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010510 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008372 0.00000